Intravenous sedation in pediatric dentistry using Midazolam, Nalbuphine and Droperidol

Alan R. Milnes, Gerardo Maupome, Jennifer Cannon

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Purpose: The purpose of this pilot investigation was to study the efficacy, physiologic responses, and safety of a multi-drug intravenous conscious sedation technique in an outpatient setting in children who demonstrated uncooperative behavior when comprehensive restorative dental treatment was attempted. Methods: Using a time-based sedation record, the physiologic responses of 153 healthy children, age range 23 months to 14.5 years, were measured after they had received midazolam (Versed), nalbuphine (Nubain), and droperidol (Inapsine), each administered intravenously, and nitrous oxide and oxygen administered by nasal mask, while each child received comprehensive restorative or surgical dental care. Each patient was monitored according to the American Academy of Pediatrics Sedation Guidelines. Heart rate and rhythm, blood pressure, respiratory rate, hemoglobin oxygen saturation, end-tidal CO2, level of sedation, and behavioral responses were recordedpreoperatively, at 5 minute intervals during treatment and in recovery until discharge. Sedation was titrated to Level 2 or 3 during treatment as defined by the American Academy of Pediatric Dentistry Reference Manual. Results: For each child, the sedation level was judged to be either acceptable or optimal for the completion of all planned dental treatment. There were no sedation failures. Children under 20 kg required significantly higher dosages of each sedative medication than children more than 20 kg to achieve the same level of sedation (P

Original languageEnglish (US)
Pages (from-to)113-119
Number of pages7
JournalPediatric Dentistry
Volume22
Issue number2
StatePublished - Mar 2000
Externally publishedYes

Fingerprint

Nalbuphine
Droperidol
Pediatric Dentistry
Midazolam
Tooth
Oxygen
Conscious Sedation
Dental Care
Nitrous Oxide
Therapeutics
Respiratory Rate
Masks
Hypnotics and Sedatives
Nose
Hemoglobins
Outpatients
Heart Rate
Guidelines
Pediatrics
Blood Pressure

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Intravenous sedation in pediatric dentistry using Midazolam, Nalbuphine and Droperidol. / Milnes, Alan R.; Maupome, Gerardo; Cannon, Jennifer.

In: Pediatric Dentistry, Vol. 22, No. 2, 03.2000, p. 113-119.

Research output: Contribution to journalArticle

@article{f92a36e9de8a4e54b971f9f6bdaac913,
title = "Intravenous sedation in pediatric dentistry using Midazolam, Nalbuphine and Droperidol",
abstract = "Purpose: The purpose of this pilot investigation was to study the efficacy, physiologic responses, and safety of a multi-drug intravenous conscious sedation technique in an outpatient setting in children who demonstrated uncooperative behavior when comprehensive restorative dental treatment was attempted. Methods: Using a time-based sedation record, the physiologic responses of 153 healthy children, age range 23 months to 14.5 years, were measured after they had received midazolam (Versed), nalbuphine (Nubain), and droperidol (Inapsine), each administered intravenously, and nitrous oxide and oxygen administered by nasal mask, while each child received comprehensive restorative or surgical dental care. Each patient was monitored according to the American Academy of Pediatrics Sedation Guidelines. Heart rate and rhythm, blood pressure, respiratory rate, hemoglobin oxygen saturation, end-tidal CO2, level of sedation, and behavioral responses were recordedpreoperatively, at 5 minute intervals during treatment and in recovery until discharge. Sedation was titrated to Level 2 or 3 during treatment as defined by the American Academy of Pediatric Dentistry Reference Manual. Results: For each child, the sedation level was judged to be either acceptable or optimal for the completion of all planned dental treatment. There were no sedation failures. Children under 20 kg required significantly higher dosages of each sedative medication than children more than 20 kg to achieve the same level of sedation (P",
author = "Milnes, {Alan R.} and Gerardo Maupome and Jennifer Cannon",
year = "2000",
month = "3",
language = "English (US)",
volume = "22",
pages = "113--119",
journal = "Pediatric Dentistry",
issn = "0164-1263",
publisher = "American Academy of Pediatric Dentistry",
number = "2",

}

TY - JOUR

T1 - Intravenous sedation in pediatric dentistry using Midazolam, Nalbuphine and Droperidol

AU - Milnes, Alan R.

AU - Maupome, Gerardo

AU - Cannon, Jennifer

PY - 2000/3

Y1 - 2000/3

N2 - Purpose: The purpose of this pilot investigation was to study the efficacy, physiologic responses, and safety of a multi-drug intravenous conscious sedation technique in an outpatient setting in children who demonstrated uncooperative behavior when comprehensive restorative dental treatment was attempted. Methods: Using a time-based sedation record, the physiologic responses of 153 healthy children, age range 23 months to 14.5 years, were measured after they had received midazolam (Versed), nalbuphine (Nubain), and droperidol (Inapsine), each administered intravenously, and nitrous oxide and oxygen administered by nasal mask, while each child received comprehensive restorative or surgical dental care. Each patient was monitored according to the American Academy of Pediatrics Sedation Guidelines. Heart rate and rhythm, blood pressure, respiratory rate, hemoglobin oxygen saturation, end-tidal CO2, level of sedation, and behavioral responses were recordedpreoperatively, at 5 minute intervals during treatment and in recovery until discharge. Sedation was titrated to Level 2 or 3 during treatment as defined by the American Academy of Pediatric Dentistry Reference Manual. Results: For each child, the sedation level was judged to be either acceptable or optimal for the completion of all planned dental treatment. There were no sedation failures. Children under 20 kg required significantly higher dosages of each sedative medication than children more than 20 kg to achieve the same level of sedation (P

AB - Purpose: The purpose of this pilot investigation was to study the efficacy, physiologic responses, and safety of a multi-drug intravenous conscious sedation technique in an outpatient setting in children who demonstrated uncooperative behavior when comprehensive restorative dental treatment was attempted. Methods: Using a time-based sedation record, the physiologic responses of 153 healthy children, age range 23 months to 14.5 years, were measured after they had received midazolam (Versed), nalbuphine (Nubain), and droperidol (Inapsine), each administered intravenously, and nitrous oxide and oxygen administered by nasal mask, while each child received comprehensive restorative or surgical dental care. Each patient was monitored according to the American Academy of Pediatrics Sedation Guidelines. Heart rate and rhythm, blood pressure, respiratory rate, hemoglobin oxygen saturation, end-tidal CO2, level of sedation, and behavioral responses were recordedpreoperatively, at 5 minute intervals during treatment and in recovery until discharge. Sedation was titrated to Level 2 or 3 during treatment as defined by the American Academy of Pediatric Dentistry Reference Manual. Results: For each child, the sedation level was judged to be either acceptable or optimal for the completion of all planned dental treatment. There were no sedation failures. Children under 20 kg required significantly higher dosages of each sedative medication than children more than 20 kg to achieve the same level of sedation (P

UR - http://www.scopus.com/inward/record.url?scp=0034149881&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034149881&partnerID=8YFLogxK

M3 - Article

C2 - 10769855

AN - SCOPUS:0034149881

VL - 22

SP - 113

EP - 119

JO - Pediatric Dentistry

JF - Pediatric Dentistry

SN - 0164-1263

IS - 2

ER -